Medicate: Healthcare Opportunities Beyond the Crisis
Date/Time
May 15, 2020
10:00 am - 11:00 am
What conversations are going on in healthcare boardrooms right now? How will the COVID-19 crisis impact healthcare dealmaking? What sectors will private equity investors and strategic buyers continue to target? What will they avoid? How will key healthcare stakeholders re-evaluate their M&A strategies? Join us on Friday, May 15th, 2020 for an exclusive video panel discussion with highly regarded healthcare dealmakers for real-time, in-depth perspectives.
Before we hear from healthcare executives on the front lines of M&A and investing, we’ll hear from Andreas Dirnagl, MUFG’s Head of Global Healthcare Research, for an update on the economic impact of COVID-19 across the healthcare ecosystem.
Date: Friday, May 15, 2020
Time: 10 a.m. PST / 1 p.m. EST
Duration: 1 hour
Opening Remarks & Moderators
 |
 |
| Adam Abramowitz Managing Director, Intrepid |
Jonathan Bluth Director, Intrepid |
Healthcare Market Observations
 |
|
Andreas J. Dirnagl |
Panelists
 |
 |
|
Jeff Bailet, MD |
Jamey Edwards |
 |
 |
| Mehran Ahmed Principal, Webster Equity |
Beth Everett Managing Director, MUFG Healthcare |